A review of hydration therapy research starts with a distinction that is often missed in wellness marketing: intravenous fluids are a well-established medical treatment for defined clinical needs, but that does not mean they are proven to improve wellbeing in every person who feels tired, busy or mildly dehydrated. The evidence is strongest where fluid loss, impaired oral intake or circulatory compromise can be identified and assessed. It is far less certain for routine elective use in otherwise well people.
For patients, this distinction supports informed consent. For clinics and practitioners, it is central to safe service design. A hydration infusion should be considered as a clinical intervention with indications, contraindications, monitoring requirements and possible harms – not as a default response to non-specific symptoms.
What hydration therapy means in clinical research
Hydration therapy usually refers to the administration of fluid to restore or maintain hydration. This can be oral, enteral or intravenous. In routine healthcare, IV fluids may contain sodium chloride, glucose, balanced electrolyte solutions or other prescribed components. The appropriate fluid, volume and rate depend on the person’s history, examination findings, observations, blood results where indicated, and the underlying cause of dehydration or illness.
Research on IV hydration therefore spans very different settings. Studies in emergency care, perioperative medicine, acute gastrointestinal illness and hospital management examine patients with identifiable clinical requirements. Elective hydration services commonly involve people outside these settings, often seeking support for fatigue, exercise recovery, travel or general wellbeing. Results from one setting cannot automatically be transferred to the other.
This matters because intravenous administration bypasses the gastrointestinal tract. It can correct deficits quickly when oral fluids are not tolerated, inadequate or medically inappropriate. Yet for mild dehydration in a person able to drink and retain fluids, oral rehydration is usually effective, less invasive and carries fewer risks.
Review of hydration therapy research by use case
Acute dehydration and impaired oral intake
The clearest evidence base supports IV fluid therapy for people who are clinically dehydrated or hypovolaemic and cannot replace fluids adequately by mouth. Examples may include significant vomiting or diarrhoea, severe illness, certain postoperative circumstances, or dehydration accompanied by concerning clinical signs. Here, IV fluids form part of established medical care, alongside investigation and treatment of the cause.
Even in these circumstances, good care is not simply a matter of giving a bag of fluid. Both too little and too much fluid can cause harm. Clinicians assess blood pressure, pulse, urine output, weight where relevant, kidney function, electrolyte levels and signs of fluid overload. The choice between fluid types and volumes is individual rather than cosmetic.
For mild to moderate dehydration, particularly from uncomplicated gastroenteritis, oral rehydration is often preferred when tolerated. Solutions containing appropriate amounts of glucose and electrolytes can promote absorption and address losses without venous access. The research does not support treating IV therapy as inherently superior merely because it is delivered intravenously.
Exercise recovery, heat and travel
Hydration is relevant to endurance exercise and hot environments, but the evidence does not establish routine IV fluids as a necessary recovery tool for healthy people after ordinary exercise or travel. In most cases, drinking fluids, eating appropriately and allowing time for recovery will restore normal hydration.
There are exceptions. Exertional heat illness, persistent vomiting, collapse, confusion, severe weakness or reduced urine output require prompt clinical assessment. In such cases, the priority is diagnosis and safe management, not a pre-selected infusion. Exercise-associated hyponatraemia – dangerously low blood sodium that can occur when fluid intake is excessive relative to losses – illustrates why hydration advice cannot be reduced to “more fluid is always better”.
Studies of post-exercise IV fluid replacement may show faster restoration of measured fluid markers under controlled conditions. That is not the same as demonstrating meaningful improvements in performance, soreness, sleep or long-term health for the typical recreational exerciser. The practical benefit depends on the degree of fluid loss, the person’s ability to drink, timing, nutrition and the demands of their activity.
Fatigue, hangover symptoms and general wellbeing
Non-specific symptoms present the greatest challenge. Fatigue, headache, low energy and feeling “run down” can be associated with inadequate fluid intake, but they may also relate to infection, sleep disruption, anaemia, medication, anxiety, endocrine conditions or many other causes. A temporary sense of improvement after receiving fluids does not establish that dehydration was the cause or that IV therapy is an appropriate ongoing response.
Evidence for elective IV hydration to treat hangover symptoms or enhance general wellness remains limited. Trials are often small, use varied fluids and outcomes, and may not separate the effects of rest, time, food, oral fluids and expectation from the infusion itself. There is insufficient high-quality evidence to support broad claims that routine IV hydration detoxifies the body, prevents illness, reverses burnout or improves immunity.
That does not invalidate a patient’s symptoms. It means responsible care should begin with assessment, realistic discussion and appropriate referral where symptoms are persistent, severe or unexplained. An infusion should never delay urgent medical attention.
What the research can and cannot tell us
Hydration research is difficult to interpret when definitions are inconsistent. “Dehydration” may be based on body mass changes, urine measures, blood tests, symptoms or clinical assessment. These measures do not always agree, especially in people who are otherwise well. Research also varies in fluid composition, infusion speed, setting and follow-up period.
The most useful questions are practical: Who was studied? What problem did they have? Was IV treatment compared with oral hydration or usual care? Did the study measure a patient-important outcome, such as avoiding hospital admission or improving function, rather than a short-term laboratory value? Were adverse effects recorded?
A single positive study should not be treated as a universal endorsement. Conversely, a lack of research in elective wellness settings does not mean that every individual experience is imaginary. It means the claims that can responsibly be made are narrow. Clinical communication should reflect that uncertainty clearly.
Safety and clinical governance are part of the evidence
The benefit of an infusion cannot be separated from its delivery. Cannulation can cause pain, bruising, failed access, inflammation of the vein and, less commonly, infection. Fluid administration can contribute to electrolyte disturbance or fluid overload, particularly in people with heart failure, kidney disease, liver disease or conditions affecting fluid balance. Allergic reactions may occur where additional ingredients are used.
A safe provider should obtain a relevant medical history, review medicines and allergies, assess contraindications and establish whether IV treatment is actually indicated. They should have clear escalation procedures, infection prevention practices, appropriately trained and professionally regulated clinicians, documentation, consent processes and access to emergency equipment and support.
In the UK, this approach also means working within appropriate professional, prescribing and medicines governance arrangements. Where prescription-only medicines or additives are involved, the legal route for prescribing and administration must be clear. Marketing should not outpace evidence, and patients should be given understandable information about expected benefits, uncertainty, alternatives and possible risks.
A proportionate approach to choosing hydration support
For someone who can drink, is alert and has no concerning symptoms, oral fluids and normal meals are often the sensible first option. Oral rehydration products may be useful after significant fluid losses, particularly when advised by a pharmacist or clinician. People with diabetes, kidney disease, heart conditions, pregnancy-related concerns or fluid restrictions should seek individual advice before making major changes to fluid or electrolyte intake.
Urgent assessment is appropriate for symptoms such as confusion, fainting, chest pain, severe breathlessness, persistent vomiting, inability to keep fluids down, very low urine output, severe abdominal pain or signs of a serious infection. These symptoms require clinical evaluation rather than elective hydration.
For elective IV therapy, a credible consultation should be willing to conclude that an infusion is not needed. It should not frame IV fluids as a substitute for investigating recurring fatigue, poor recovery or ongoing gastrointestinal symptoms. The quality of the decision is as important as the procedure itself.
Hydration therapy has an important place in healthcare when it addresses a defined clinical need and is delivered with appropriate assessment and oversight. For everyone else, the most reassuring answer is not necessarily the quickest intervention, but a careful explanation of what the evidence supports, what it does not, and what should happen next.